Biotech Week articles from January 2004

Biotech Week archives from January 2004

Drug-coated biomaterials prevent artery reblockage.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Cornell University Professor C.C. Chu was browsing through Business Week in 1997 when he read about a cardiologist using radioactivity to reduce artery reblockage following angioplasty and stent...

Data reported in trials of heat shock protein-based cancer vaccines.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Antigenics, Inc., (AGEN) announced updated results from clinical trials of HSPPC-70 (previously referred to as AG-858) and Oncophage (HSPPC-96) personalized cancer vaccines, both of which are based on...

FDA advisory panel backs easier morning-after pill.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Women may soon have an easier way to help prevent pregnancy after unprotected sex now that government advisers have supported over-the-counter sales of the so-called "morning-after pill." "It's...

Large dimeric ligands possess PPAR agonist activity in vivo.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Large dimeric ligands possess favorable pharmacokinetic properties and peroxisome proliferator-activated receptor (PPAR) agonist activity in vitro and in vivo. According to a study from Denmark,...

Study to provide more data on targeted 5-day radiotherapy for DCIS patients.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Proxima Therapeutics, Inc., announced the initiation of the largest partial breast irradiation study for patients with ductal carcinoma in situ (DCIS). The study will be conducted at six breast...

Data on next-generation VEGF cancer agent presented at ASH.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- The first in the next generation of vascular endothelial growth factor (VEGF) inhibiting agents - those that employ a three-prong approach to inhibiting tumor growth - can be administered safely in a...

Crossreactive antibodies against Plasmodium protein induced.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Researchers have reported the induction of crossreactive antibodies to Plasmodium falciparum variant protein. "The variant antigen Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1),...

Nanotech-based hydrogel launched.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- 3DM, Inc., introduced its PuraMatrix line of synthetic peptide hydrogels at the 43rd annual conference of the American Society for Cell Biology (ASCB) in San Francisco. Their line of biomaterials...

Phase I study of SC12267 initiated.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- 4SC announced the start of clinical phase I trials of its first small molecule product candidate SC12267 for the treatment of rheumatoid arthritis. In this study the compound will be examined with...

Post-tamoxifen use of Femara reduces risk of breast cancer recurrence by 43%.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Extended adjuvant treatment with Femara (letrozole tablets) in a group of postmenopausal women with early breast cancer who had completed 5 years of therapy with tamoxifen cut the risk of recurrence of...

John Weinstein, MD, PhD, appointed to scientific advisory board.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- ACLARA BioSciences (ACLA) announced that John N. Weinstein, MD, PhD, of Bethesda, Maryland, has been appointed to its scientific advisory board. Weinstein's research focus is the molecular...

AIDS group releases white paper urging new HIV prevention strategies.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- With World AIDS Day observations concluded for another year, AIDS Project Los Angeles (APLA) has announced the publication of "Changing How We Think: HIV Prevention Policy in the U.S.," a white paper...

Diagnostics firm announces ISO 13485 audit complete.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- AMDL, Inc., (Amex: ADL; Berlin, Frankfurt), developer and marketer of tests for the early detection of cancer and other serious diseases, said that it has successfully undergone an extensive audit to...

Preclinical data on microbubble drug delivery reported.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- AVI BioPharma, Inc., (AVII) announced the presentation of preclinical data at two international conferences. The first presentation detailed a novel drug delivery mechanism, AVI's proprietary...

Dendritic cell vaccine to be used in trial for new cancer treatment.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Aastrom Biosciences, Inc., (ASTM) announced the initiation of a phase I clinical trial in collaboration with investigators at Duke University Medical Center (Duke). The clinical trial will evaluate...

Alliance formed to develop an automated test to monitor transplant drug.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Abbott Laboratories announced a collaboration and license agreement with Wyeth to develop an automated blood test to monitor therapeutic levels of the anti-rejection drug Rapamune (sirolimus). ...

Research suggests more needs to be done to protect at-risk infants from RSV.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- New clinical data provide additional evidence that premature (i.e., less than or equal to 35 weeks gestational age [wGA]) infants are at elevated risk for respiratory syncytial virus (RSV)-related...

New targets for therapy in prostate cancer discussed.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- A quantitative assay for DD3(PCA3) could have important implications for the earlier diagnosis and molecular staging of prostate cancer. "Identification of new markers for diagnosis and new targets...

BLA filed for Arilvax vaccine.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Acambis plc (ACAM) announced that it has filed a Biologics License Application (BLA) with the CBER vaccine division of the U.S. Food and Drug Administration (FDA) to seek registration in the U.S. of its...

Matrix VSG System pivotal clinical trial commences.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- AccessClosure, Inc., announced that it has commenced a clinical trial in the U.S. on the use of its Matrix VSG System, at the Washington Adventist Hospital, Takoma Park, MD. The Matrix VSG System...

Growth of extracranial radiosurgery highlighted at CyberKnife Users' Meeting.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Accuray, Inc., a company focused on full-body image-guided radiosurgery, held the third annual CyberKnife Users' Meeting. Extracranial radiosurgery using the CyberKnife Stereotactic Radiosurgery...

Agreement signed to acquire noncancer assets from Cadherin.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Adherex Technologies, Inc., (AHX) announced that it has signed a memorandum of agreement to acquire noncancer related cadherin-based intellectual property from Cadherin Biomedical, Inc. (CBI). The...

Escherichia coli adheres to bladder epithelium with fimbriae, sialic acid.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Escherichia coli adheres to bladder epithelium with fimbriae, and nonspecifically with sialic acid. "The first step in the bacterial colonization and infection of uropathogenic Escherichia coli is...

AVR118 suppresses progression of disease in animal model.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corp. (ADVR) announced that administration of its novel immunomodulator AVR118 (formerly known as Product R) in animals with induced experimental allergic encephalomyelitis (EAE)...

Hawkins named to board of directors at viral disease drug company.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Advanced Viral Research Corporation (ADVR) announced that Elma S. Hawkins, PhD, MBA, has been appointed to the company's board of directors and named a member of the executive management committee,...

Senior management team strengthened at pharmaceutical firm.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Advancis Pharmaceutical Corporation (AVNC), a pharmaceutical company focused on developing and commercializing novel anti-infective products, announced that it has added two key executives to lead the...

Phase II study of aerosolized amikacin completed in critical care setting.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Aerogen, Inc., (AEGN) announced completion of its first phase II clinical study evaluating delivery of aerosolized amikacin for the treatment of ventilator-associated pneumonia. These data have...

Studies highlight aerosol generator technology in infant mechanical ventilation.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Aerogen, Inc., (AEGN) reported on data presented at the American Association for Respiratory Care (AARC) 49th Annual International Respiratory Congress, which highlights applications of Aerogen's OnQ...

Aetna signs contract renewals with two northern Virginia hospitals.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Aetna (AET) announced that it has signed contract extensions with Reston (Virginia) Hospital Center and Northern Virginia Community Hospital. The new contracts will enable Aetna members in Northern...

Alliance to advance whole transcript analysis.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Affymetrix, Inc., (AFFX) and Nugen Technologies, Inc., a privately held company developing and commercializing products for high sensitivity nucleic acid amplification and detection, announced that they...

Vectosomes improve the delivery of antisense oligonucleotides.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Vectosomes improve the delivery of antisense oligonucleotides. "VP22, a protein of the herpes simplex virus tegument, can form complexes with fluorescein-labeled oligonucleotides. These particles,...

Advances in tuberculosis research offer novel vaccine strategy insights.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Advances in antibody-mediated immunity against Mycobacterium tuberculosis have provided insights for developing novel vaccine strategies. "Cell-mediated immunity is considered to be the major...

Human antibodies from immunized donors protect against anthrax.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Human antibodies from immunized donors are protective against anthrax toxin in vivo. "A panel of Fabs that neutralize anthrax toxin in vitro was selected from libraries generated from human donors...

Orphan drug designation granted in U.S., Europe for Eculizumab.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Alexion Pharmaceuticals, Inc., (ALXN) announced that both the U.S. Food and Drug Administration (FDA) and the European Agency for the Evaluation of Medicinal Products have granted eculizumab orphan drug...

Significant reduction in heavy drinking seen in phase III trial Of Vivitrex.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Alkermes, Inc., (ALKS) announced preliminary results from its phase III study of Vivitrex (naltrexone for injectable suspension) in a total of 624 male and female patients with alcohol dependence. ...

InterfeRx licensing program launched for RNAi therapeutics.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Alnylam Pharmaceuticals, Inc., announced the launch of the InterfeRx licensing program for RNAi therapeutics. Through the InterfeRx program, Alnylam will grant licenses for the development of RNAi...

An invagination technique treats esophagogastric end-to-end anastomoses.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- For end-to-end esophagogastrostomy, researchers recommend an anastomotic technique due to its simplicity and low anastomotic leakage rate. According to recent research published in the journal...

Senior R&D executive to lead product development.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Altea Therapeutics has appointed David J. Enscore, PhD, as senior VP for product research & development. Enscore is responsible for leading all of the company's pharmaceutical product research and...

Two siRNA libraries launched.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Ambion announced the launch and availability of two siRNA libraries: the first targets 597 human kinases and the second targets 441 human G protein-coupled receptors (GPCRs). The kinase siRNA...

AmeriHealth to cover FluMist due to vaccine shortage.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- In response to the reported shortage of injectible flu vaccines, AmeriHealth announced that for the remainder of this flu season, the insurer will expand its coverage of flu vaccines to include the...

Univ. of Buffalo, military collaborate on design, testing of first drug to prevent deafness.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Six hundred marines at Camp Pendleton in California will undergo 2 weeks of war games in the coming months armed with a new weapon: a drug designed to protect their hearing from the destructive decibels...

Modified Rotterdam Symptom Checklist is reliable, valid for cancer patient use.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- The modified Rotterdam Symptom Checklist (RSCL-M) is a reliable and valid instrument for use with cancer patients in the United States, researchers say. "The Rotterdam Symptom Checklist (RSCL) is a...

Disease management company appoints chief medical officer.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- American Healthways, Inc., (AMHC) announced the appointment of James E. Pope, MD, to the newly created position of executive vice president and chief medical officer. Pope has previously served as...

Chinese biotech to apply for listing on primary U.S. stock exchange.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- American Oriental Bioengineering, Inc., announced that it would apply for a full listing on one of the primary U.S. stock exchanges over the next few weeks. The company anticipates it will apply to...

FDA grants approval for Piperacillin injection.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- American Pharmaceutical Partners, Inc., (APPX), announced that it has received approval from the U.S. Food and Drug Administration (FDA) to launch Piperacillin for injection, USP, the generic equivalent...

Positive Abraxane phase III data released.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- American Pharmaceutical Partners, Inc., (APPX) (APP) and ABRAXIS Oncology, the proprietary drug division of APP, announced positive results of the randomized, controlled phase III clinical trial in...

New pharmacy automation system launched.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- AmerisourceBergen Corporation (ABC) launched the AutoMed Efficiency Pharmacy H750, the first radio frequency identification (RFID) enabled hospital pharmacy automation and barcoding system for all types...

Phase III data show that Palifermin improves oral mucositis in cancer patients.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Amgen (AMGN) announced additional data from a phase III study demonstrating that treatment with palifermin (recombinant human keratinocyte growth factor or rHuKGF), an investigational product, was...

Beier named senior VP, global government affairs at biotech firm.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Amgen, Inc., (AMGN) announced that David Beier has been named senior vice president, Global Government Affairs. Beier will be responsible for the operations of Amgen's Washington, DC, office and...

Pharmaceutical company files shelf registration statement.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Amylin Pharmaceuticals, Inc., (AMLN) announced that it has filed a shelf registration statement with the U.S. Securities and Exchange Commission (SEC). Upon being declared effective by the SEC, the...

Deal signed for generic oral contraceptive products.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Andrx Corporation (ADRX) and Teva Pharmaceutical Industries, Ltd., (TEVA) jointly announced that they have entered into a strategic collaboration to develop and market generic oral contraceptive...

Phase II study of Acclaim initiated.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Angiogenix, Inc., announced the initiation of a phase II clinical trial of its lead product candidate, Acclaim, for the treatment of chronic angina, the chest pain that occurs from inadequate blood flow...

New stem-cell transplantation drug addresses unmet need in cancer patients.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- AnorMED, Inc., (AOM) announced that AMD3100, its lead drug candidate for stem cell transplantation, helps cancer patients who would otherwise be unable to undergo a stem cell transplant because they...

Milestone payment made for needle-free technology.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Antares Pharma, Inc., (ANTR) announced that it has received a milestone payment from Eli Lilly and Company (LLY), the licensee of Antares Pharma's needle-free injection technology in the fields of...

DNA technology company completes initial bridge financing.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Applied DNA Sciences, Inc., (APDN) announced that its placement agent Vertical Capital Partners, Inc., has closed on its initial $750,000 bridge financing commitment. The bridge financing was made...

NF2 gene overexpression thwarts schwannoma cell growth.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- NF2 gene overexpression thwarts schwannoma cell growth. "The loss of NF2 gene function leads to vestibular nerve schwannoma formation in humans. The NF2 gene product, Merlin/Schwannomin, has...

New eco-evolutionary model of tumor dynamics described.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Researchers describe a new eco-evolutionary model of tumor dynamics that incorporates stoichiometric mechanisms. According to a study from the United States, "Biological stoichiometry is the study...

Researchers uncover pathway that could lead to plant generation of human-like protein.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Researchers led by Lokesh Joshi, an Arizona State University (ASU) associate professor in the Harrington department of bioengineering of the Ira A. Fulton School of Engineering and a member of the...

Scientists investigate childhood nutrition mystery's causes, effects.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Scientists funded by the U.S. Agricultural Research Service are investigating how nutrition may affect children who develop normally in most ways but grow slowly in the first 3 years of life....

Positive data reported on phase II breast tumor cell proliferation study.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Ascend Therapeutics, Inc., announced that it presented data from a phase II dose-escalating study comparing the antiproliferative effect of the company's percutaneous TamoGel (4-Hydroxytamoxifen gel) to...

Data presented on oral anticoagulant after total knee replacement surgery.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Results of a phase III clinical trial comparing AstraZeneca's investigational oral anticoagulant Exanta (ximelagatran) with warfarin in patients following total knee replacement (TKR) surgery were...

Deal signed for solid-tumor cancer treatment development.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Avanir Pharmaceuticals (AVN) announced that a commercial license agreement with Peregrine Pharmaceuticals, Inc., (PPHM) has been executed for an antibody Avanir produced for a cancer target in...

Shipment of about 43M doses of influenza vaccine completed.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Aventis announced that the company has completed shipment of approximately 43 million doses of its influenza vaccine (Fluzone, Influenza Virus Vaccine) to customers for the 2003-04 influenza season. ...

Anti-inflammatory cytokine technology licensed.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Avigen, Inc., (AVGN) announced that it has exclusively licensed rights to the treatment of chronic pain using anti-inflammatory cytokines, including interleukin 10 (IL-10), from the University of...

Positive ITAX phase II results reported.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Axcan Pharma, Inc., disclosed efficacy and safety results of a phase II study related to ITAX (Itopride hydrochloride or Itopride), a patented oral gastroprokinetic drug with antiemetic properties...

Palmar plating for unstable Colles fractures yield excellent results.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Palmar plating for unstable Colles fractures yield excellent and good results in 20 patients, researchers report. "A prospective study was done in 20 patients with unstable Colles' fractures with...

Report asks: Has the pharmaceutical blockbuster model gone bust?
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- The pharmaceutical industry's blockbuster approach to developing new drugs that created a trillion dollars for shareholders may now be broken. And the demise is being fueled by a...

Global reach expanded with formation of two marketing partnerships.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Barrier Therapeutics, Inc., announced that it has established agreements with Alliance Pharmaceuticals, Ltd., and Neopharm, Ltd., for the marketing, sales, and distribution of Barrier's initial...

Hemostatic potential of factor VIII-heparin cofactor II proteins assessed.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Researchers evaluated the hemostatic potential of factor VIII-heparin cofactor II hybrid proteins in a mouse model. "We constructed factor VIII-heparin cofactor II (FVIII-HCII) hybrid molecules,...

Data support safety, efficacy of Advate.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Study results on Baxter Healthcare Corporation's Advate Antihemophilic Factor (Recombinant), Plasma/Albumin-Free Method (rAHF-PFM), presented at the 45th Annual Meeting and Exposition of the American...

Multiyear contract awarded for IV solutions, sets to veterans hospitals.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Baxter Healthcare Corporation announced that it has been awarded a multiyear contract by the Department of Veterans Affairs for the exclusive sale of its intravenous solutions and sets to the more than...

Ileoinguinal tumors should be considered for primary excision, reconstruction.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Ileoinguinal tumors should be considered for primary excision and reconstruction, followed by radiation, if necessary, researchers say. According to published research from the United States,...

Application filed for approval of Bio-Set drug delivery device for Kogenate.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Bayer Biological Products (BP) announced that its extension application requesting approval for Bio-Set, a new needleless device for reconstitution and use of Kogenate Bayer (Antihemophilic Factor...

Survey shows antibiotics initially ineffective in some sinusitis patients.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Almost 40% of acute bacterial sinusitis sufferers report the antibiotic they were initially prescribed did not work the first time, according to a national survey conducted by Wirthlin Worldwide. ...

A new improved culture system scales up gene vector production.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- A new improved culture system scales up gene vector production. According to a study from the United States, "helper-dependent adenoviral vectors (HDAds) are devoid of all viral coding sequences and...

Compounding issues become more complex with introduction of new bio-technologies.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Ethical, legal, and social issues are becoming more complex as new genetic and molecular techniques are used to study environmental toxicants and their potential influence on human and ecologic health,...

Extraarticular impingement can be avoided by careful removal of excess cement.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- In the majority of cases, extraarticular impingement can be avoided by careful removal of excess cement and extracortical osteophytes, researchers report. "In this study, we examine the...

Homes should be smoke-free zones soon after baby's birth.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- New mothers who want to establish a no-smoking policy in their homes are more likely to have the policy stick if they start it early, soon after the birth of their children. "Our results suggest...

Oral drug shows promise for prevention of ER-negative disease in mouse model.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- The oral drug ZD1839, also known as gefitinib, prevented the development of estrogen receptor (ER)-negative breast cancer in a mouse model, which raises the possibility that the drug could be a...

SAFB1 and SAFB2 may be novel breast tumor suppressor genes.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Scaffold attachment factor B1 (SAFB1) and Scaffold attachment factor B2 (SAFB2) may be novel breast tumor suppressor genes, researchers say. "SAFB1 and SAFB2 are large, multifunctional proteins that...

High-resolution cell imaging technologies acquired from Q3DM.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Beckman Coulter, Inc., (BEC) announced that it has acquired the assets of Q3DM, Inc., which includes Q3DM's cell imaging platform, software and cell imaging applications used in pharmaceutical research,...

Integra syringe maximizes current flu vaccination supply.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- A 10-dose vial of flu vaccine can provide 11 vaccinations when delivered with a Becton, Dickinson and Company (BD) Integra Syringe, BD advises healthcare providers. The syringe is designed with a...

Outbreak in Beijing spread rapidly, was controlled fairly quickly.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Improving triage in hospitals and dissemination of information to the public helped bring a rapid resolution to the spread of severe acute respiratory syndrome (SARS) in Beijing in early 2003, according...

Pharmaceutical firm's redeemable warrants expire.
January 7, 2004... 2004 JAN 7 - (NewsRx.com & NewsRx.net) -- Bentley Pharmaceuticals, Inc., (BNT) issued a reminder to the market that the company's Class B Warrants (BNT_TB) expired at the close of business on December 31, 2003, as scheduled. All...